FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087491092> ?p ?o ?g. }

• W3087491092 endingPage "941" @default.
• W3087491092 startingPage "929" @default.
• W3087491092 abstract "Abstract BACKGROUND In our recent individual participant data (IPD) meta-analysis evaluating the effectiveness of first-line ovulation induction for polycystic ovary syndrome (PCOS), IPD were only available from 20 studies of 53 randomized controlled trials (RCTs). We noticed that the summary effect sizes of meta-analyses of RCTs without IPD sharing were different from those of RCTs with IPD sharing. Granting access to IPD for secondary analysis has implications for promoting fair and transparent conduct of RCTs. It is, however, still common for authors to choose to withhold IPD, limiting the impact of and confidence in the results of RCTs and systematic reviews based on aggregate data. OBJECTIVE AND RATIONALE We performed a meta-epidemiologic study to elucidate if RCTs without IPD sharing have lower quality and more methodological issues than those with IPD sharing in an IPD meta-analysis evaluating first-line ovulation induction for PCOS. SEARCH METHODS We included RCTs identified for the IPD meta-analysis. We dichotomized RCTs according to whether they provided IPD (shared group) or not (non-shared group) in the IPD meta-analysis. We restricted RCTs to full-text published trials written in English. We assessed and compared RCTs in the shared and non-shared groups on the following criteria: Risk of Bias (RoB 2.0), GRADE approach, adequacy of trial registration; description of statistical methods and reproducibility of univariable statistical analysis; excessive similarity or difference in baseline characteristics that is not compatible with chance; and other miscellaneous methodological issues. OUTCOMES In total, 45 trials (8697 women) were included in this study. IPD were available from 17 RCTs and 28 trials were categorized as the non-shared IPD group. Pooled risk rates obtained from the shared and non-shared groups were different. Overall low risk of bias was associated with 13/17 (76%) of shared RCTs versus 7/28 (25%) of non-shared RCTs. For RCTs that started recruitment after 1 July 2005, adequate trial registration was found in 3/9 (33%) of shared IPD RCTs versus 0/16 (0%) in non-shared RCTs. In total, 7/17 (41%) of shared RCTs and 19/28 (68%) of non-shared RCTs had issues with the statistical methods described. The median (range) of inconsistency rate per study, between reported and reproduced analyses for baseline variables, was 0% (0–92%) (6 RCTs applicable) in the shared group and 54% (0–100%) (13 RCTs applicable) in the non-shared group. The median (range) of inconsistency rate of univariable statistical results for the outcome(s) per study was 0% (0–63%) (14 RCTs applicable) in the shared group and 44% (0–100%) (24 RCTs applicable) in the non-shared group. The distributions of simulation-generated P-values from comparisons of baseline continuous variables between intervention and control arms suggested that RCTs in the shared group are likely to be consistent with properly conducted randomization (P = 0.163), whereas this was not the case for the RCTs in the non-shared group (P = 4.535 × 10−8). WIDER IMPLICATIONS IPD meta-analysis on evaluating first-line ovulation induction for PCOS preserves validity and generates more accurate estimates of risk than meta-analyses using aggregate data, which enables more transparent assessments of benefits and risks. The availability of IPD and the willingness to share these data may be a good indicator of quality, methodological soundness and integrity of RCTs when they are being considered for inclusion in systematic reviews and meta-analyses." @default.
• W3087491092 created "2020-09-25" @default.
• W3087491092 creator A5001037085 @default.
• W3087491092 creator A5018646147 @default.
• W3087491092 creator A5022380857 @default.
• W3087491092 creator A5047480968 @default.
• W3087491092 creator A5053933535 @default.
• W3087491092 creator A5060831453 @default.
• W3087491092 creator A5060892833 @default.
• W3087491092 creator A5082289384 @default.
• W3087491092 creator A5090339348 @default.
• W3087491092 date "2020-09-16" @default.
• W3087491092 modified "2023-09-24" @default.
• W3087491092 title "To share or not to share data: how valid are trials evaluating first-line ovulation induction for polycystic ovary syndrome?" @default.
• W3087491092 cites W1540803043 @default.
• W3087491092 cites W1803012365 @default.
• W3087491092 cites W1965700219 @default.
• W3087491092 cites W1973497290 @default.
• W3087491092 cites W1976404584 @default.
• W3087491092 cites W1982643634 @default.
• W3087491092 cites W1992531651 @default.
• W3087491092 cites W1993237761 @default.
• W3087491092 cites W1996445345 @default.
• W3087491092 cites W1997124292 @default.
• W3087491092 cites W2003219636 @default.
• W3087491092 cites W2011503021 @default.
• W3087491092 cites W2015919165 @default.
• W3087491092 cites W2019711414 @default.
• W3087491092 cites W2030062166 @default.
• W3087491092 cites W2032293423 @default.
• W3087491092 cites W2036436500 @default.
• W3087491092 cites W2072581605 @default.
• W3087491092 cites W2072620887 @default.
• W3087491092 cites W2076863250 @default.
• W3087491092 cites W2085332384 @default.
• W3087491092 cites W2086084736 @default.
• W3087491092 cites W2086285589 @default.
• W3087491092 cites W2100306033 @default.
• W3087491092 cites W2126438731 @default.
• W3087491092 cites W2126651730 @default.
• W3087491092 cites W2128848153 @default.
• W3087491092 cites W2129308211 @default.
• W3087491092 cites W2131091609 @default.
• W3087491092 cites W2137670391 @default.
• W3087491092 cites W2137832653 @default.
• W3087491092 cites W2138595862 @default.
• W3087491092 cites W2139871014 @default.
• W3087491092 cites W2140695894 @default.
• W3087491092 cites W2144135547 @default.
• W3087491092 cites W2150748027 @default.
• W3087491092 cites W2170892587 @default.
• W3087491092 cites W2175990978 @default.
• W3087491092 cites W2560296895 @default.
• W3087491092 cites W2566467546 @default.
• W3087491092 cites W2581580243 @default.
• W3087491092 cites W2585913005 @default.
• W3087491092 cites W2588666165 @default.
• W3087491092 cites W2604378711 @default.
• W3087491092 cites W2619022048 @default.
• W3087491092 cites W2726145925 @default.
• W3087491092 cites W2727551680 @default.
• W3087491092 cites W2753394018 @default.
• W3087491092 cites W2784631229 @default.
• W3087491092 cites W2921782175 @default.
• W3087491092 cites W2947641233 @default.
• W3087491092 cites W2981633327 @default.
• W3087491092 cites W2982131198 @default.
• W3087491092 cites W2994804923 @default.
• W3087491092 cites W3004499776 @default.
• W3087491092 cites W3020841070 @default.
• W3087491092 cites W4212784858 @default.
• W3087491092 doi "https://doi.org/10.1093/humupd/dmaa031" @default.
• W3087491092 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32935841" @default.
• W3087491092 hasPublicationYear "2020" @default.
• W3087491092 type Work @default.
• W3087491092 sameAs 3087491092 @default.
• W3087491092 citedByCount "9" @default.
• W3087491092 countsByYear W30874910922021 @default.
• W3087491092 countsByYear W30874910922022 @default.
• W3087491092 countsByYear W30874910922023 @default.
• W3087491092 crossrefType "journal-article" @default.
• W3087491092 hasAuthorship W3087491092A5001037085 @default.
• W3087491092 hasAuthorship W3087491092A5018646147 @default.
• W3087491092 hasAuthorship W3087491092A5022380857 @default.
• W3087491092 hasAuthorship W3087491092A5047480968 @default.
• W3087491092 hasAuthorship W3087491092A5053933535 @default.
• W3087491092 hasAuthorship W3087491092A5060831453 @default.
• W3087491092 hasAuthorship W3087491092A5060892833 @default.
• W3087491092 hasAuthorship W3087491092A5082289384 @default.
• W3087491092 hasAuthorship W3087491092A5090339348 @default.
• W3087491092 hasBestOaLocation W30874910921 @default.
• W3087491092 hasConcept C126322002 @default.
• W3087491092 hasConcept C168563851 @default.
• W3087491092 hasConcept C189708586 @default.
• W3087491092 hasConcept C2777391703 @default.
• W3087491092 hasConcept C2777702977 @default.
• W3087491092 hasConcept C2779306644 @default.
• W3087491092 hasConcept C2779473830 @default.

• next